Publication Date | Title | Author(s) |
May-2021 | COVID-19 living evidence profile #3 (version 3.1): What is known about how schools (K-12) and postsecondary institutions (colleges and universities) adjust COVID-19 transmission-mitigation measures as infection rates change and vaccination rates increase? | Bain, T; Bhuiya, AR; Al-Khateeb, S; Wang, Q; Mansilla, C; Rintjema, J; DeMaio, P; Alam, S; Gauvin, François-Pierre; Santesso, N; Lavis, JN; Wilson, MG |
Jun-2021 | COVID-19 living evidence profile #3 (version 3.2): What is known about how schools (K-12) and postsecondary institutions (colleges and universities) adjust COVID-19 transmission-mitigation measures as infection rates change and vaccination rates increase? | Bain, T; Bhuiya, AR; Al-Khateeb, S; Wang, Q; Mansilla, C; DeMaio, P; Rintjema, J; Abeer, A; Gauvin, François-Pierre; Matthews, M; Lavis, JN; Wilson, MG |
Sep-2021 | COVID-19 living evidence profile #3 (version 3.3): What is known about how schools (K-12) and post-secondary institutions (colleges and universities) adjust COVID-19 transmission-mitigation measures as infection rates change and vaccination rates increase? | Bain, T; Bhuiya, AR; Al-Khateeb, S; Wang, Q; Mansilla, C; Rintjema, J; DeMaio, P; Matthews, M; Lavis, JN; Wilson, MG |
May-2020 | COVID-19 rapid evidence profile #11: What is the evidence related to playground equipment and risk of COVID-19 transmission? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Sharma, K; Lavis, JN |
Sep-2020 | COVID-19 rapid evidence profile #19: What is the risk of transmission of COVID-19 in hospital and long-term care settings, and the impacts of hospital-visitor policies? | Waddell, K; Wilson, MG; Moat, KA; Wang, Q; Gauvin, François-Pierre; Ahmad, A; Alam, S; Bhuiya, AR; Tchakerian, N; Lavis, JN |
Apr-2020 | COVID-19 rapid evidence profile #3: What is the evidence about international and Canadian experiences with asymptomatic screening to identify COVID-19 cases and to prevent transmission? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
Apr-2020 | COVID-19 rapid evidence profile #4: What are the most effective non-medical masks for preventing community transmission of COVID-19, and should they be required for all of society? | Wilson, MG; Gauvin, François-Pierre; Moat, KA; Waddell, K; Mansilla, C; Wang, Q; Lavis, JN |
Apr-2020 | COVID-19 rapid evidence profile #5: What is known about the use of medical masks by essential non-medical workers to prevent community transmission of COVID-19? | Waddell, K; Gauvin, François-Pierre; Wilson, MG; Moat, KA; Mansilla, C; Wang, Q; Lavis, JN |
Jan-2024 | Living evidence profile 7.1: Examining what is known about the emergence, transmission and spectrum of the burden of disease of avian influenza A (H5Nx) subtypes | Bhuiya, AR; Bain, T; Dass, R; Chen, K; Wilson, MG |
May-2024 | Living evidence profile 7.2: Examining what is known about the emergence, transmission and spectrum of the burden of disease of avian influenza A (H5Nx) subtypes | Bhuiya, AR; Bain, T; Waddell, K; Ali, A; DeMaio, P; Moat, K; Wilson, MG |
May-2024 | Living evidence profile 7.3: Examining what is known about the emergence, transmission, and spectrum of the burden of disease of avian influenza A(H5Nx) subtypes | Bhuiya, AR; Bain, T; Alam, S; Ciurea, P; Chen, K; Velez, CM; Wu, N; Wang, Q; Waddell, K; DeMaio, P; Wilson, MG |
Jul-2024 | Living evidence profile 7.4: Examining what is known about the emergence, transmission, and spectrum of the burden of disease of avian influenza A(H5Nx) subtypes | Bhuiya, AR; Bain, T; Ciurea, P; Alam, S; Grewal, E; Dass, R; Ali, A; Wu, N; Waddell, K; DeMaio, P; Wilson, MG |
Jan-2024 | Profil de preuves vivantes 7.1 : Examen de ce que l’on sait au sujet de l’émergence, de la transmission et du spectre de la charge de morbidité des sous-types de la grippe aviaire A(H5Nx) | Bhuiya, AR; Bain, T; Dass, R; Chen, K; Wilson, MG |
May-2024 | Profil de preuves vivantes 7.3 : Examen de ce qui est connu au sujet de l’émergence, de la transmission et du spectre du fardeau de la maladie des sous-types de l’influenza aviaire A(H5Nx) | Bhuiya, AR; Bain, T; Alam, S; Ciurea, P; Chen, K; Velez, CM; Wu, N; Wang, Q; Waddell, K; DeMaio, P; Wilson, MG |
Jul-2024 | Profil de preuves vivantes 7.4 : Examen de ce qui est connu au sujet de l’émergence, de la transmission et du spectre du fardeau de la maladie des sous-types de l’influenza aviaire A(H5Nx) | Bhuiya, AR; Bain, T; Alam, S; Ciurea, P; Chen, K; Velez, CM; Wu, N; Wang, Q; Waddell, K; DeMaio, P; Wilson, MG |